Literature DB >> 34070275

Neuroprotective Natural Products for Alzheimer's Disease.

Xin Chen1, Joshua Drew1, Wren Berney1, Wei Lei2.   

Abstract

Alzheimer's disease (AD) is the number one neurovegetative disease, but its treatment options are relatively few and ineffective. In efforts to discover new strategies for AD therapy, natural products have aroused interest in the research community and in the pharmaceutical industry for their neuroprotective activity, targeting different pathological mechanisms associated with AD. A wide variety of natural products from different origins have been evaluated preclinically and clinically for their neuroprotective mechanisms in preventing and attenuating the multifactorial pathologies of AD. This review mainly focuses on the possible neuroprotective mechanisms from natural products that may be beneficial in AD treatment and the natural product mixtures or extracts from different sources that have demonstrated neuroprotective activity in preclinical and/or clinical studies. It is believed that natural product mixtures or extracts containing multiple bioactive compounds that can work additively or synergistically to exhibit multiple neuroprotective mechanisms might be an effective approach in AD drug discovery.

Entities:  

Keywords:  Alzheimer’s disease (AD); amyloid β peptide (Aβ); anti-neuroinflammatory; antioxidant; natural products; neurodegenerative; neurofibrillary tangles (NFTs); neuroprotective

Year:  2021        PMID: 34070275     DOI: 10.3390/cells10061309

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  258 in total

1.  Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.

Authors:  Annadurai Anandhan; Kuppusamy Tamilselvam; Thangaiyan Radhiga; Shalinee Rao; Musthafa Mohamed Essa; Thamilarasan Manivasagam
Journal:  Brain Res       Date:  2011-11-13       Impact factor: 3.252

2.  Artemisinin B Improves Learning and Memory Impairment in AD Dementia Mice by Suppressing Neuroinflammation.

Authors:  Weijie Qiang; Weiyan Cai; Qing Yang; Lan Yang; Yifei Dai; Zheng Zhao; Jie Yin; Yujie Li; Qi Li; Yajie Wang; Xiaogang Weng; Dong Zhang; Ying Chen; Xiaoxin Zhu
Journal:  Neuroscience       Date:  2018-11-03       Impact factor: 3.590

3.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

4.  Contribution of Alzheimer disease to mortality in the United States.

Authors:  Bryan D James; Sue E Leurgans; Liesi E Hebert; Paul A Scherr; Kristine Yaffe; David A Bennett
Journal:  Neurology       Date:  2014-03-05       Impact factor: 9.910

5.  Resveratrol-mediated cleavage of amyloid β1-42 peptide: potential relevance to Alzheimer's disease.

Authors:  Sarmad Al-Edresi; Izzeddin Alsalahat; Sally Freeman; Harmesh Aojula; Jeffrey Penny
Journal:  Neurobiol Aging       Date:  2020-04-20       Impact factor: 4.673

6.  Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.

Authors:  Fiona Kerr; Oyinkan Sofola-Adesakin; Dobril K Ivanov; Jemma Gatliff; Beatriz Gomez Perez-Nievas; Hélène C Bertrand; Pedro Martinez; Rebecca Callard; Inge Snoeren; Helena M Cochemé; Jennifer Adcott; Mobina Khericha; Jorge Iván Castillo-Quan; Geoffrey Wells; Wendy Noble; Janet Thornton; Linda Partridge
Journal:  PLoS Genet       Date:  2017-03-02       Impact factor: 5.917

Review 7.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

8.  Anti-inflammatory Effects of Curcumin in Microglial Cells.

Authors:  Yangyang Yu; Qian Shen; Yihong Lai; Sun Y Park; Xingmei Ou; Dongxu Lin; Meiling Jin; Weizhen Zhang
Journal:  Front Pharmacol       Date:  2018-04-20       Impact factor: 5.810

Review 9.  History and progress of hypotheses and clinical trials for Alzheimer's disease.

Authors:  Pei-Pei Liu; Yi Xie; Xiao-Yan Meng; Jian-Sheng Kang
Journal:  Signal Transduct Target Ther       Date:  2019-08-23

10.  Comparative study of korean white, red, and black ginseng extract on cholinesterase inhibitory activity and cholinergic function.

Authors:  Mi Ra Lee; Beom Sik Yun; Oh Hyun In; Chang Keun Sung
Journal:  J Ginseng Res       Date:  2011-11       Impact factor: 6.060

View more
  11 in total

Review 1.  Natural Therapeutics in Aid of Treating Alzheimer's Disease: A Green Gateway Toward Ending Quest for Treating Neurological Disorders.

Authors:  Basharat Ahmad Bhat; Abdullah Almilaibary; Rakeeb Ahmad Mir; Badr M Aljarallah; Wajahat R Mir; Fuzail Ahmad; Manzoor Ahmad Mir
Journal:  Front Neurosci       Date:  2022-05-16       Impact factor: 5.152

Review 2.  Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer's Disease.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Harun-Or-Rashid; Md Saidur Rahaman; Mohamed H Nafady; Md Rezaul Islam; Aklima Akter; Talha Bin Emran; Polrat Wilairatana; Mohammad S Mubarak
Journal:  Oxid Med Cell Longev       Date:  2022-04-11       Impact factor: 7.310

Review 3.  Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases.

Authors:  Faheem Hyder Pottoo; Abdallah Mohammad Ibrahim; Ali Alammar; Rida Alsinan; Mahdi Aleid; Ali Alshehhi; Muruj Alshehri; Supriya Mishra; Noora Alhajri
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-27

4.  Epigallocatechin Gallate Modulates Essential Elements, Zn/Cu Ratio, Hazardous Metal, Lipid Peroxidation, and Antioxidant Activity in the Brain Cortex during Cerebral Ischemia.

Authors:  Ming-Cheng Lin; Chien-Chi Liu; Yu-Chen Lin; Ching-Wen Hsu
Journal:  Antioxidants (Basel)       Date:  2022-02-16

Review 5.  Selected Natural Products in Neuroprotective Strategies for Alzheimer's Disease-A Non-Systematic Review.

Authors:  Karolina Wojtunik-Kulesza; Tomasz Oniszczuk; Jarosław Mołdoch; Iwona Kowalska; Jarosław Szponar; Anna Oniszczuk
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 6.  The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment.

Authors:  Tarek Zieneldien; Janice Kim; Chuanhai Cao
Journal:  Geriatrics (Basel)       Date:  2022-02-26

7.  The anti-Alzheimer potential of Tamarindus indica: an in vivo investigation supported by in vitro and in silico approaches.

Authors:  Abeer H Elmaidomy; Usama Ramadan Abdelmohsen; Faisal Alsenani; Hanan F Aly; Shams Gamal Eldin Shams; Eman A Younis; Kawkab A Ahmed; Ahmed M Sayed; Asmaa I Owis; Naglaa Afifi; Dalia El Amir
Journal:  RSC Adv       Date:  2022-04-19       Impact factor: 4.036

Review 8.  Alzheimer's Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore.

Authors:  Maria João Botelho; Jelena Milinovic; Narcisa M Bandarra; Carlos Vale
Journal:  Mar Drugs       Date:  2022-04-02       Impact factor: 6.085

9.  Active Compounds and Targets of Yuanzhi Powder in Treating Alzheimer's Disease and Its Relationship with Immune Infiltration Based on HPLC Fingerprint and Network Pharmacology.

Authors:  Qingsong Liu; Shaofeng Wang; Yanwei Hao; Jiaxin Li; Wei Li; Yi Zhang; Bin Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-15       Impact factor: 2.650

Review 10.  Ginkgo biloba in the Aging Process: A Narrative Review.

Authors:  Sandra Maria Barbalho; Rosa Direito; Lucas Fornari Laurindo; Ledyane Taynara Marton; Elen Landgraf Guiguer; Ricardo de Alvares Goulart; Ricardo José Tofano; Antonely C A Carvalho; Uri Adrian Prync Flato; Viviane Alessandra Capelluppi Tofano; Cláudia Rucco Penteado Detregiachi; Patrícia C Santos Bueno; Raul S J Girio; Adriano Cressoni Araújo
Journal:  Antioxidants (Basel)       Date:  2022-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.